The effect of low dose versus standard dose of arterial heparin on vascular complications ‎following transradial coronary angiography: Randomized controlled clinical trial

<p><strong>BACKGROUND:</strong> The potential risk of vascular complications associated with heparin, the dose of heparin therapy has not been exactly examined in patients undergoing transradial angiography. Thus, this study was aimed to compare referral arterial thrombosis, hemato...

Full description

Bibliographic Details
Main Authors: Farshad Roghani, Babak Shirani, Omid Hashemifard
Format: Article
Language:English
Published: Vesnu Publications 2016-01-01
Series:ARYA Atherosclerosis
Subjects:
Online Access:http://arya.mui.ac.ir/index.php/arya/article/view/1215
_version_ 1818026620976365568
author Farshad Roghani
Babak Shirani
Omid Hashemifard
author_facet Farshad Roghani
Babak Shirani
Omid Hashemifard
author_sort Farshad Roghani
collection DOAJ
description <p><strong>BACKGROUND:</strong> The potential risk of vascular complications associated with heparin, the dose of heparin therapy has not been exactly examined in patients undergoing transradial angiography. Thus, this study was aimed to compare referral arterial thrombosis, hematoma and hemorrhagic complications with 2500 and 5000 IU arterial heparin and the association of these complications with predictors in patients undergoing diagnostic angiography.</p> <p><strong>METHODS:</strong> This prospective, randomized, double-blind controlled trial was carried out on 441 patients aged &ge; 18-year-old in Isfahan, Iran. They were referred for diagnostic coronary angiography with radial access. First participants were randomized into to inject either 2500 IU (group A) or 5000 IU (group B) of heparin. Study&rsquo;s primary endpoints were thrombosis, hematoma, and hemorrhage.</p> <p><strong>RESULTS:</strong> The frequency of thrombosis was 25.5% in group A vs. 2.3% in group B (P &lt; 0.001), while the frequency of hematoma had no significant differences in group A and B. None of patients in both groups had hemorrhage. Using 5000 IU of heparin protected the occurrence of thrombosis by 95% [odds ratio (OR): 0.05, 95% confidence interval (CI): 0.02-012] after adjustment for confounders.</p> <p><strong>CONCLUSION:</strong> The low dose (2500 IU) versus standard dose (5000 IU) of heparin use increased the risk of thrombosis following trans-radial diagnostic coronary angiography, with no effect on hematoma and bleeding.</p>
first_indexed 2024-12-10T04:34:54Z
format Article
id doaj.art-21f0aa6ed6be41c2ae69459da6a6e2ad
institution Directory Open Access Journal
issn 1735-3955
2251-6638
language English
last_indexed 2024-12-10T04:34:54Z
publishDate 2016-01-01
publisher Vesnu Publications
record_format Article
series ARYA Atherosclerosis
spelling doaj.art-21f0aa6ed6be41c2ae69459da6a6e2ad2022-12-22T02:02:02ZengVesnu PublicationsARYA Atherosclerosis1735-39552251-66382016-01-011211017571The effect of low dose versus standard dose of arterial heparin on vascular complications ‎following transradial coronary angiography: Randomized controlled clinical trialFarshad Roghani0Babak Shirani1Omid Hashemifard2Associate Professor, Interventional Cardiologist, Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, ‎Isfahan, IranResident, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, IranInterventional Cardiologist, Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical ‎Sciences, Isfahan, Iran<p><strong>BACKGROUND:</strong> The potential risk of vascular complications associated with heparin, the dose of heparin therapy has not been exactly examined in patients undergoing transradial angiography. Thus, this study was aimed to compare referral arterial thrombosis, hematoma and hemorrhagic complications with 2500 and 5000 IU arterial heparin and the association of these complications with predictors in patients undergoing diagnostic angiography.</p> <p><strong>METHODS:</strong> This prospective, randomized, double-blind controlled trial was carried out on 441 patients aged &ge; 18-year-old in Isfahan, Iran. They were referred for diagnostic coronary angiography with radial access. First participants were randomized into to inject either 2500 IU (group A) or 5000 IU (group B) of heparin. Study&rsquo;s primary endpoints were thrombosis, hematoma, and hemorrhage.</p> <p><strong>RESULTS:</strong> The frequency of thrombosis was 25.5% in group A vs. 2.3% in group B (P &lt; 0.001), while the frequency of hematoma had no significant differences in group A and B. None of patients in both groups had hemorrhage. Using 5000 IU of heparin protected the occurrence of thrombosis by 95% [odds ratio (OR): 0.05, 95% confidence interval (CI): 0.02-012] after adjustment for confounders.</p> <p><strong>CONCLUSION:</strong> The low dose (2500 IU) versus standard dose (5000 IU) of heparin use increased the risk of thrombosis following trans-radial diagnostic coronary angiography, with no effect on hematoma and bleeding.</p>http://arya.mui.ac.ir/index.php/arya/article/view/1215Coronary AngiographyThrombosisHemorrhageHematoma
spellingShingle Farshad Roghani
Babak Shirani
Omid Hashemifard
The effect of low dose versus standard dose of arterial heparin on vascular complications ‎following transradial coronary angiography: Randomized controlled clinical trial
ARYA Atherosclerosis
Coronary Angiography
Thrombosis
Hemorrhage
Hematoma
title The effect of low dose versus standard dose of arterial heparin on vascular complications ‎following transradial coronary angiography: Randomized controlled clinical trial
title_full The effect of low dose versus standard dose of arterial heparin on vascular complications ‎following transradial coronary angiography: Randomized controlled clinical trial
title_fullStr The effect of low dose versus standard dose of arterial heparin on vascular complications ‎following transradial coronary angiography: Randomized controlled clinical trial
title_full_unstemmed The effect of low dose versus standard dose of arterial heparin on vascular complications ‎following transradial coronary angiography: Randomized controlled clinical trial
title_short The effect of low dose versus standard dose of arterial heparin on vascular complications ‎following transradial coronary angiography: Randomized controlled clinical trial
title_sort effect of low dose versus standard dose of arterial heparin on vascular complications ‎following transradial coronary angiography randomized controlled clinical trial
topic Coronary Angiography
Thrombosis
Hemorrhage
Hematoma
url http://arya.mui.ac.ir/index.php/arya/article/view/1215
work_keys_str_mv AT farshadroghani theeffectoflowdoseversusstandarddoseofarterialheparinonvascularcomplicationsfollowingtransradialcoronaryangiographyrandomizedcontrolledclinicaltrial
AT babakshirani theeffectoflowdoseversusstandarddoseofarterialheparinonvascularcomplicationsfollowingtransradialcoronaryangiographyrandomizedcontrolledclinicaltrial
AT omidhashemifard theeffectoflowdoseversusstandarddoseofarterialheparinonvascularcomplicationsfollowingtransradialcoronaryangiographyrandomizedcontrolledclinicaltrial
AT farshadroghani effectoflowdoseversusstandarddoseofarterialheparinonvascularcomplicationsfollowingtransradialcoronaryangiographyrandomizedcontrolledclinicaltrial
AT babakshirani effectoflowdoseversusstandarddoseofarterialheparinonvascularcomplicationsfollowingtransradialcoronaryangiographyrandomizedcontrolledclinicaltrial
AT omidhashemifard effectoflowdoseversusstandarddoseofarterialheparinonvascularcomplicationsfollowingtransradialcoronaryangiographyrandomizedcontrolledclinicaltrial